Could Merck Become Pharma's Yield King? Analyst expects the company will boost dividend after its merger with Schering-Plough. Matthew Herper, 05.29.09, Originally published in Forbes.com Merck could increase the size of the dividend payment it makes to shareholders every … [Read more...] about Merck Merger Mints Money
MERCK Watch
Merck Has Demonstrated A Corporate Culture Of Deception
Merck published fake journal The following is an excerpted article that was originally published in TheScientist.com. To read the full article, with citations, click on the hyper link below. The Inconvenient Woman thought it was very important to illustrate the prevasive … [Read more...] about Merck Has Demonstrated A Corporate Culture Of Deception
Merck Puts Some of Their Gardasil Cash To Work
Merck to buy Schering-Plough in $41 billion deal Reported by David Jolly Publ With the purchase, Merck is expanding its franchise in cardiovascular, respiratory and oncology drugs and shoring up its research pipeline, in particular with a Schering-Plough product called TRA, a … [Read more...] about Merck Puts Some of Their Gardasil Cash To Work
2008 Was Not a Good Year for Merck
Gardasil HPV-Vaccine is Just One Of Merck's Troublesome Issues The forth quarter earning reports, the report card for publicly held companies, held no good news for Merck or its stockholders. Merck released its not overly optimistic guidance for 2009 that forecasted earnings and … [Read more...] about 2008 Was Not a Good Year for Merck
Merck Faces Another Tough Year
What happened to Merck chief Richard amazing turnaround? Has Merck's comeback turned into a wipeout? Under chief Richard Clark, an unassuming company lifer, Merck (nyse: MRK - news - people ) staged a seemingly amazing turnabout from the dark days of 2004, when … [Read more...] about Merck Faces Another Tough Year